Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs

Leuk Lymphoma. 2015 May;56(5):1507-9. doi: 10.3109/10428194.2014.955021. Epub 2014 Oct 7.

Authors

Mariasanta Napolitano¹, Giorgia Saccullo, Roberto Bono, Antonio Branca, Clotilde Cangialosi, Salvatrice Mancuso, Simona Raso, Gerlando Quintini, Maria Grazia Lipari, Francesco Fabbiano, Giorgina Specchia, Alberto Dolce, Francesco Di Raimondo, Sergio Siragusa

Affiliation

¹ Cattedra ed U.O. di Ematologia con trapianto, Policlinico Universitario di Palermo , Palermo, Sicily.

PMID: 25139690
DOI: 10.3109/10428194.2014.955021

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents / therapeutic use
Female
Humans
Immunologic Factors / therapeutic use
Lymphocyte Count*
Male
Middle Aged
Multiple Myeloma / drug therapy
Multiple Myeloma / immunology*
Multiple Myeloma / mortality*
Prognosis

Substances

Antineoplastic Agents
Immunologic Factors